Journal article
Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
Abstract
Objective: To undertake a 1-year prospective economic evaluation of ciprofloxacin compared with usual antibacterial care (any antibacterial other than a quinolone) for the treatment of acute exacerbations of chronic bronchitis (AECB) in adults presenting with a type I or type II AECB.Design: Patients entered the study with an initial AECB and were randomised to the ciprofloxacin group or the usual care group. The following measurements were …
Authors
Torrance G; Walker V; Grossman R; Mukherjee J; Vaughan D; La Forge J; Lampron N
Journal
PharmacoEconomics, Vol. 16, No. 5, pp. 499–520
Publisher
Springer Nature
Publication Date
11 1999
DOI
10.2165/00019053-199916050-00007
ISSN
1170-7690